Identification and Validation of METTL3-Related Molecules for Predicting Prognosis and Efficacy of Immunotherapy in Gastric Cancer Based on m6A Methylome and Transcriptome Sequencing Analysis

Abnormal N6-methyladenosine (m6A) modification levels caused by METTL3 have been identified to be a critical regulator in human cancers, and its roles in the immune microenvironment and the relationship between targeted therapy and immunotherapy sensitivity in gastric cancer (GC) remain poorly under...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shuran, Su, Xu, Wang, Jing, Zheng, Ni, Tang, Yuan, Peng, Guisen, Dong, Rui, Lu, Fei, Liu, Mulin, Zhao, Yunli, Wu, Huazhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373839/
https://www.ncbi.nlm.nih.gov/pubmed/35965524
http://dx.doi.org/10.3389/fonc.2022.935239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373839/
https://www.ncbi.nlm.nih.gov/pubmed/35965524
http://dx.doi.org/10.3389/fonc.2022.935239

Ejemplares similares